(Q35219131)

7 August 2017

1 reference

title

Drug effects on salivary glands: dry mouth (English)

1 reference

7 August 2017

1

Scully C

1 reference

7 August 2017

publication date

1 July 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

9

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

165-176

1 reference

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized contr

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Xerostomia, xerogenic medications and food avoidances in selected geriatric groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Tolterodine: a safe and effective treatment for older patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Variations among non-sedating antihistamines: are there real differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Salivary function and hypertension: a review of the literature and a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Oxybutynin for detrusor instability with adjuvant salivary stimulant pastilles to improve compliance: results of a multicentre, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder

21 January 2018

2 references

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

21 January 2018

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

A Review of the Pharmacological and Clinical Profile of Mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Effects of furosemide on the oral cavity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Nutritional implications of xerostomia and rampant caries caused by serotonin reuptake inhibitors: a case study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Drug treatment of obesity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer pain. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

The salivary glands. Embryology, anatomy, and surgical applications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Phase II trial of systemic recombinant interleukin-2 in the treatment of refractory nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Tolterodine: a review of its use in the treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Extended-release oxybutynin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Open label evaluation of cannabidiol in dystonic movement disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

A Controlled Comparative Trial of Mianserin and Diazepam in the Treatment of Anxiety States in Psychiatric Out-Patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Xerostomia in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Drugs and the geriatric patient: a review of problems and special considerations faced by the dentist

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Adverse effects of antiretroviral therapy: focus on orofacial effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Xerostomia associated with didanosine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Olanzapine for schizophrenia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Alprazolam and diazepam in the treatment of generalized anxiety

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Age and medication are significant risk factors for xerostomia in an English population, attending general dental practice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Acquired salivary dysfunction. Drugs and radiation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Dental conditions in patients with bipolar disorder on long-term lithium maintenance therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Current pharmacotherapeutic strategies for overactive bladder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Phase I trial of retinol in cancer patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Anti-retroviral drugs--implications for dental prescribing.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Tricyclic drugs for depression in children and adolescents.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

13-cis-retinoic acid in conglobate acne. A follow-up study of 14 trial centers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Donepezil for psychotropic-induced memory loss.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

[Receptive systems for drugs in salivary gland cells]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Specific side effects of long-term imipramine management of panic disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Saliva in non-insulin-dependent diabetic patients and control subjects: The role of the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Major salivary gland dysfunction in patients with hematological malignancies receiving interleukin-2-based immunotherapy post-autologous blood stem cell transplantation (ABSCT)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

The effect of low-dose interleukin-2-based immunotherapy on salivary function and composition in patients with metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Xerostomia and hyposalivation: causes, consequences and treatment in the elderly

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Systemic oral isotretinoin therapy and flow rate, pH, and matrix metalloproteinase-9 activity of stimulated saliva

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Differences in salivary flow rates in elderly subjects using xerostomatic medications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

HIV topic update: protease inhibitor therapy and oral health care

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Update on rilmenidine: clinical benefits

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Tramadol: a review of its use in perioperative pain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Oral side-effects of the most frequently prescribed drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

A reference guide to drugs and dry mouth--2nd edition

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Quetiapine for schizophrenia.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Pharmacological interventions for spasticity following spinal cord injury

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Omeprazole and dry mouth

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Dental caries experience and use of prescription medications among people aged 60+ in South Australia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Medication and dry mouth: findings from a cohort study of older people

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Is medication a risk factor for dental caries among older people?. Evidence from a longitudinal study in South Australia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Understanding salivary fluid and protein secretion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Xerostomia associated with didanosine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Cetirizine/pseudoephedrine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Venlafaxine extended-release: a review of its use in the management of major depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Morphine responses in humans: a retrospective analysis of sex differences

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

Centrally acting antihypertensive drugs. Present and future

1 reference

https://api.crossref.org/works/10.1034%2FJ.1601-0825.2003.03967.X

7 January 2021

10.1034/J.1601-0825.2003.03967.X

Identifiers

DOI

1 reference

7 August 2017

1 reference